CORD-19:e847d433e7424152a9846673209cb73027415ecd / 347422-347779 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/e847d433e7424152a9846673209cb73027415ecd","sourcedb":"CORD-19","sourceid":"e847d433e7424152a9846673209cb73027415ecd","text":"In comparative clinical studies, the novel potent statin rosuvastatin demonstrated a hylipidemic activity significantly greater compared with that of atorvastatin, simvastatin or pravastatin, associated with more contained risks of pharmacological interactions with all molecules metabolized by the liver cytochrome P450 (including HIV protease inhibitors).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3197","span":{"begin":0,"end":357},"obj":"Sentence"},{"id":"T59074","span":{"begin":0,"end":357},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T3197","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T59074","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T64","span":{"begin":0,"end":357},"obj":"Sentence"}],"attributes":[{"subj":"T64","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T249","span":{"begin":299,"end":304},"obj":"Body_part"}],"attributes":[{"id":"A249","pred":"uberon_id","subj":"T249","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"subj":"T249","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ccec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93e6"},{"id":"CORD-19-PD-UBERON","color":"#93ecd8"}]}]}}